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SUMMARY.-The action of 6-thioguanine on the division of PHA-stimulated
humanlymphocytes in vitro has been investigated and shown to have a definite
antimitotic effect which is prevented by adenine but notbyguanine orhypoxan-
thine. It is suggested that in this test system 6-TG exerts its main inhibitory
action on phosphoribosylpyrophosphate amidotransferase.
THE guanine analogue, 6-thioguanine (6-TG) is an antimetabolite which has
been shown to have growth inhibitory activity in a number of systems particu-
larly cancer cells. It causes complete regression of established sarcoma 180
tumours in mice (Adams and Bowman, 1963) and in the concentration range of
0-1-0-01 mg./ml. it causes 50% inhibition ofgrowth ofcultured humanepidermoid
carcinoma (KB) cells (Eagle andFoley, 1958). 6-TG has also been usedtherapeu-
tically in man, particularly in the treatment of acute leukaemia in children
(Burchenal etal., 1956) and in chronicmyeloid leukaemia. In order to obtain some
insight into the possible mode ofits action it was decided to investigate the effect
of 6-TG on phytohaemagglutinin (PHA)-stimulated normal human lymphocytes
in vitro.
MATERIALS AND METHODS
Bloodsamples were obtained fromhealthy volunteers and lymphocyte cultures
were set up as follows. About 20 ml. of venous blood was mixed immediately
with anticoagulant (heparin in dextran) in a sterile container. The erythrocytes
were allowed to settle at 37' C. and the supernatant plasma and leucocytes were
drawn off. 1-5 ml. of the cell plasma suspension was made up to 10 ml. with
TC199 culture medium (Glaxo) and two drops of reconstituted PHA P (Difco)
were added to each culture which was then incubated at 37' C. for 72 hours.
At the end ofthisperiod, 0-2 ml. of
" Colcemid
" (demecolcine) at a concentration
oflmg.inlOOml.ofTC199wasadded. Thecultureswereincubatedforafurther
2 hours. The cells were then spun down, the supernatant discarded and the cells
resuspended in hvpotonic saline for 15 minutes at 37' C. After this time, they
were fixed in two changes of acetic alcohol (I part glacial acetic acid : 3 parts ethanol) and resuspended in 45% acetic acid to give a translucent suspension. The cells were then spread on to cold slides, air clried and stained with IO% Giemsa buffered at pH 6-4.
The following experiments were done. In the first, the experimental cultures
were exposed to varying concentrations of 6-TG throughout the 72-hour period. In subsequent experiments, equimolecular concentrations of 6-TG and eitherANTIMITOTIC EFFECT OF 6-THIOGUANINE 107
guanine, hypoxanthine, or adenine were administered simultaneously at the start
of the 72-hour period. Each series of experiments was performed in triplicate.
Control cultures treated in the same way, except that no 6-TG, guanine, hypoxan-
thine, or adenine was added, were set up at the same time.
One thousand cells per culture were examined and the number of cells in
mitosis noted. The averaged results for each series of experiments are given,
expressed as apercentage ofthe control values.
RESTJLTS
The results given in Table I show that at concentrations of 10-3m and above
6-TG completely prevents mitosis and appears to kill many of the cells since
TABLEI.-The Effect ofPurines on the Antimitotic Activity of6-thioguanine
6-TG and
6-TG alone 6-TG and gilanine hypoxanthine 6-TG and adenine
r- A
) r A
A 11 A
) 11 A
Molar No. of No. of No. of No. of
concentration mitoses mitoses mitoses mitoses
of each per I000 % per I000 % per I000 % per I000 %
added purine cells control cells control cells control cells contrul
10-2 0 0 0 0 0 0 0 0
10-3 0 0 1 1.8 3 14-8 1 3-5
10-4 4-3 23-9 1 1-8 6-7 33 26-5 93
10-5 4 22-2 6 10-8 7 34-5 26-5 93
10-6 12 66-7 15-7 77-3 38 133-3
0 18 100 55-5 100 20-3 100 28-5 100
(control)
morphological transformation in response to PHA is markedly reduced. Between
concentrations of 10-6m and 10-4M, 6-TG caused inhibition of mitosis but had
little effect on the transformation rate. Neither guanine, hypoxanthine nor
adenine is able to remove the effect of 6-TG at 10-2m and 10-3M. Addition of
guanine enhances the antimitotic activity of 6-TG and hypoxanthine has little
effect on its action. However, between concentrations of 10-6m and 10-4M
adenine protects the cells against this effect so that the mitotic index (number of
mitoses/1000 cells) remains essentially the same as that ofthe control.
DISCITSSION
In the cell, 6-TG is converted to its active metabolite 6-thioguanylic acid
(6-thio GMP) by the action of guanine-hypoxanthine phosphoribosyltransferase
on 5-phosphoribosyl-l-py-rophosphate (PRPP) and 6-TG (Brockman, 1963). In
this form it has been shown to act at a number ofstages in thepurinebiosynthetic
pathway. McCollister et al. (1964) have shown that it exerts a pseudofeedback
effect in inhibiting the action of the enzyme phosphoribosylpyrophosphate
amidotransferase from pigeon liver. This enzyme catalyses the formation of
5 -phosphoribosyl-l-aminefromPRPP. Hampton(I963)withAerobacteraerogenes
and Meich et al. (1967) with sarcoma 180 ascites cells have shown that 6-thio
GMPinhibitstheenzymeinosine5'-phosphatedehydrogenase(IMPdehydrogenase)
which catalyses the conversion of inosinic acid (IMP) to xanthylic acid (XMP).
Meich et al. (1967) also report the inhibitory action of 6-thio GMP on ATP : GMP
phosphotransferase isolated from hog brain tissues, which converts guanylic acid
(GMP) to guanosine 5'-diphosphate (GDP). Any of these effects would limit the108 D. J. PRICE AND J. TIMSON
amount of guanine nucleotides formed both to act as coenzymes and in nucleic
acidsynthesis, thusresulting in inhibition ofnucleic acidsynthesis withconsequent
inhibition in mitotic activity. Le Page (1960) has reported the incorporation of
small amounts of 6-thio GMP into nucleic acids of tumour cells. Furthermore,
cells which incorporate 6-TG into their DNA remain viable but do not replicate
their DNA (Le Page and Jones, 1961; Le Page, 1963).
Clearly the antimitotic effect of 6-TG on cultured lymphocytes could be
explained by one or more of the above effects. However the results given in
Table I suggest the possibility that 6-TG may be exerting its prime effect in this
system early in the purine biosyntheticpathway. Purine bases can be converted
to their corresponding ribonucleotidesbyreacting with PRPP. For this reaction,
both guanine and hypoxanthine require guanine-hypoxanthine phosphoribosyl-
transferase, the same enzyme which converts 6-TG to 6-thio GMP. Since neither
guanine norhypoxanthine can reverse the antimitotic activity of 6-TG it suggests
that 6-T G competes successfully with these purines for this enzyme, so that the
guanine and hypoxanthine are not in fact utilized by the cell. The increase in
antimitotic activity when guanine is administered with 6-TG is probablydue. to a
cytotoxic effect since transformation was also slightly lowered.
Adenine requires a different enzyme-adenine phosphoribosyltransferase-to
convert it to the ribonucleotide adenylic acid (AMP) and may therefore compete
with the 6-TG for the available PRPP. This would result in a lowering of the
active amount of 6-thio GMP formed and hence account for the prevention of
antimitotic activity.
It is alsopossible that some ofthe AMP formed inthis way couldbe deaminated
to IMP and hence lead to the formation ofXMP and GMP. Ifthe maininhibitory
action of 6-TG was on phosphoribosylpyrophosphate amidotransferase, then the
activity of any 6-thio GMP which was formed could be bypassed and a supply
ofpurine ribonucleotides,ensured so that mitotic activity could proceednormally.
Thus 6-TG seems to reactpreferentially withguanine-hypoxanthinephosphori-
bosyltransferase in the presence of equal concentrations of either guanine or
hvpoxanthine but adenine appears to preferentially utilize the available PRPP
in human lymphocytes when 6-TG and adenine are both present. This might be
expected in view ofthe role which ATPplays in the energyrelationships ofthe cell.
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